SG2013079843A - Use of tocotrienols in the treatment or prevention of ulcerative colitis - Google Patents
Use of tocotrienols in the treatment or prevention of ulcerative colitisInfo
- Publication number
- SG2013079843A SG2013079843A SG2013079843A SG2013079843A SG2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A
- Authority
- SG
- Singapore
- Prior art keywords
- tocotrienols
- prevention
- treatment
- ulcerative colitis
- ulcerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2013079843A SG2013079843A (en) | 2013-10-25 | 2013-10-25 | Use of tocotrienols in the treatment or prevention of ulcerative colitis |
PCT/SG2014/000500 WO2015060789A1 (en) | 2013-10-25 | 2014-10-24 | Use of tocotrienols in the treatment or prevention of ulcerative colitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG2013079843A SG2013079843A (en) | 2013-10-25 | 2013-10-25 | Use of tocotrienols in the treatment or prevention of ulcerative colitis |
Publications (1)
Publication Number | Publication Date |
---|---|
SG2013079843A true SG2013079843A (en) | 2015-05-28 |
Family
ID=52993257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2013079843A SG2013079843A (en) | 2013-10-25 | 2013-10-25 | Use of tocotrienols in the treatment or prevention of ulcerative colitis |
Country Status (2)
Country | Link |
---|---|
SG (1) | SG2013079843A (en) |
WO (1) | WO2015060789A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200093751A1 (en) * | 2016-06-28 | 2020-03-26 | Der-Yang Tien | Chemoprotective/chemoactive nanodroplets and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214373B1 (en) * | 1999-10-07 | 2001-04-10 | Snowden-Sutton Associates, Inc. | Nutritional composition for treating inflammatory bowel diseases |
US20050107465A1 (en) * | 2003-10-01 | 2005-05-19 | Papas Andreas M. | Composition for treating inflammatory bowel disease |
-
2013
- 2013-10-25 SG SG2013079843A patent/SG2013079843A/en unknown
-
2014
- 2014-10-24 WO PCT/SG2014/000500 patent/WO2015060789A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015060789A1 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253580A1 (en) | Use of cannabinoids in the treatment of epilepsy | |
IL251529A0 (en) | Use of cannabinoids in the treatment of epilepsy | |
PT3334422T (en) | Use of cannabinoids in the treatment of epilepsy | |
PL3157512T3 (en) | Use of cannabidiol in the treatment of epilepsy | |
HK1246296A1 (en) | Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections | |
HK1246295A1 (en) | Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections | |
EP2954376A4 (en) | Fluid treatment methods and systems | |
GB201400442D0 (en) | Compositions for use in the treatment of ulcerative colitis | |
EP3030343A4 (en) | Novel fluid treatment systems and methods | |
HUE044216T2 (en) | Chitin or derivatives thereof for the prevention and/or treatment of parasitoses | |
IL252493B (en) | Compounds for use in the prevention or treatment of cancer | |
SG2013079843A (en) | Use of tocotrienols in the treatment or prevention of ulcerative colitis | |
PL2862576T3 (en) | Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis | |
HK1209033A1 (en) | Use of odiparcil in the treatment of mucopolysaccharidosis | |
HUE047636T2 (en) | Arginine for use in the treatment and/or prevention of osteoarthritis | |
AP2015008726A0 (en) | Low-glycerin-formulations for hiv treatment and prevention | |
PL3041459T3 (en) | Compositions useful in the prevention or treatment of skin cancer | |
GB201312597D0 (en) | TrailerSafe reversing and safety aid | |
GB201421889D0 (en) | Improvements in or relating to effluent treatment | |
GB201319614D0 (en) | Fluid treatment |